Burgos-Burgos Javier, Pinar-Sedeño Beatriz, García-Cabrera Laura, Rodríguez-Ibarria Nieves, Cabezón-Pons Auxiliadora, Lloret-Sáenz-Bravo Marta, Vicente-Rubio Elena, Vega-Benítez Víctor, Travieso-Aja María, Lara Pedro C
Oncology Department, San Roque University Hospital, Las Palmas de Gran Canaria, Spain.
Radiation Oncology Department, Dr. Negrin University Hospital, Las Palmas de Gran Canaria, Spain.
Transl Cancer Res. 2020 Jan;9(Suppl 1):S207-S216. doi: 10.21037/tcr.2019.08.38.
Breast cancer is the most common cancer pathology in women in the Western world. The median age at diagnosis is 60 years and in the coming decades it is estimated that the number of elderly women affected reaches an important percentage. This aging of the cancer population, associated with its inherent comorbidities and aggravated by the lack of consensus about the most appropriate treatment, make it difficult to administer an effective postoperative treatment in elderly women with a low-risk profile. An exhaustive geriatric evaluation is a sine qua non condition to opt for a specific type of treatment. To date, several options are available such as endocrine therapy (ET) alone, moderate/high hypofractionation and various accelerated partial breast irradiation (APBI) techniques. In this article, we provide information about each of them.
乳腺癌是西方世界女性中最常见的癌症病理类型。诊断时的中位年龄为60岁，预计在未来几十年中，受影响的老年女性数量将达到相当大的比例。癌症患者群体的老龄化，加上其固有的合并症，以及由于对最合适的治疗方法缺乏共识而加剧的情况，使得对低风险特征的老年女性进行有效的术后治疗变得困难。详尽的老年医学评估是选择特定治疗类型的必要条件。迄今为止，有几种选择，如单独的内分泌治疗（ET）、中等/高度低分割放疗以及各种加速部分乳腺照射（APBI）技术。在本文中，我们提供了关于它们每一种的信息。
